Lung Cancer
FORTIS-M: A Phase 3, randomized, double-blind, placebo-controlled study of oral talactoferrin in addition to best supportive care in patients with non-small cell lung cancer who have failed two or more prior treatment regimens
Trial ID: 07057
Contact: Kelli S Watkins
Phone: (281)863-2443
Learn More about this trial.
go back | new search